A Study to Assess the Effectiveness and Safety of Treatment With Vedolizumab in Adult Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real Life

TerminatedOBSERVATIONAL
Enrollment

29

Participants

Timeline

Start Date

February 13, 2018

Primary Completion Date

February 15, 2019

Study Completion Date

February 15, 2019

Conditions
Colitis, UlcerativeCrohn DiseaseInflammatory Bowel Diseases
Trial Locations (13)

Unknown

Centre Hospitalier Cote Basque, Bayonne

Ch de Blois, Blois

Clinique du palais, Grasse

Ghef Ch Marne La Vallee, Jossigny

Ctre Hosp St Joseph Et St Luc, Lyon

Hopital Edouard Herriot, Lyon

Hopital Saint Eloi-Chru Montpellier, Montpellier

Ch Lyon Sud, Pierre-Bénite

Polyclinique Cote Basque Sud, Saint-Jean-de-Luz

HOPITAL NORD-CHU de SAINT-ETIENNE, Saint-Priest-en-Jarez

Clinique Ambroise Pare, Toulouse

HOPITAUX DE BRABOIS-CHRU de NANCY, Vandœuvre-lès-Nancy

Gh mutualiste les portes du sud, Vénissieux

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY